Dr. Jonathan L. Carter, M.D.
Neurology (Neurology Physician)
13400 E Shea Blvd
Scottsdale, AZ 85259
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Mayo Medical School (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 211
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: Mayo Medical School
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
AZ license 16388
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mayo Clinic Hospital Phoenix, AZ
- Huhu Kam Memorial Hospital Sacaton, AZ
Medical groups
- Mayo Clinic Arizona (1,626 clinicians)
- Gila River Health Care Corporation (247 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 211
- Services billed
- 360
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Needle measurement of electrical activity in arm or leg muscles, complete study | 59 | 53 |
| Established patient office or other outpatient visit, 40-54 minutes | 57 | 56 |
| New patient office or other outpatient visit, 60-74 minutes | 46 | 46 |
| Established patient office or other outpatient visit, 30-39 minutes | 38 | 35 |
| Nerve conduction, 3-4 studies | 23 | 23 |
| Nerve conduction, 5-6 studies | 19 | 19 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 17 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Baclofen Other prescribers in Scottsdale, AZ | 54 |
| Modafinil Other prescribers in Scottsdale, AZ | 49 |
| Gabapentin Other prescribers in Scottsdale, AZ | 46 |
| Fingolimod (fingolimod hcl) | 36 |
| Copaxone (glatiramer acetate) | 23 |
| Dalfampridine Er (dalfampridine) | 20 |
| Clonazepam Other prescribers in Scottsdale, AZ | 12 |
| Enspryng (satralizumab-mwge) | 12 |
| Zaleplon Other prescribers in Scottsdale, AZ | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 6 payments worth $12,375 in total to this clinician.
| H. Lundbeck A S | $12,375 |
|---|
| Honoraria | $12,375 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| H. Lundbeck A S Jan 6, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,700 |
| H. Lundbeck A S Jan 2, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,250 |
| H. Lundbeck A S Jan 2, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,250 |
| H. Lundbeck A S Oct 15, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,250 |
| H. Lundbeck A S Jan 6, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,025 |
| H. Lundbeck A S Oct 15, 2025 | Honoraria VYEPTI · NEUROLOGY | $900 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,459 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)
UCB SA · Active, not recruiting · NCT05063162
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.